BVS | Bioventus Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)

*Sign In to persist settings

Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2015-12-31	2014-12-31	2013-12-31
Revenue	512.35M	512.12M	430.90M	321.16M	340.14M	319.18M	253.65M	N/A	N/A
Cost of Revenue	192.99M	181.04M	128.19M	87.64M	90.94M	84.17M	74.34M	N/A	N/A
Gross Profit	319.35M	331.08M	302.71M	233.52M	249.21M	235.01M	179.31M	N/A	N/A
Operating Expenses	303.34M	379.70M	281.65M	211.72M	217.44M	207.64M	173.76M	N/A	N/A
Selling, General & Admin	289.89M	332.61M	254.25M	193.08M	198.47M	191.67M	148.44M	147.06M	150.37M
Research & Development	13.45M	25.94M	19.04M	11.20M	11.05M	8.10M	14.75M	N/A	N/A
Other Operating Expenses	1.29M	21.15M	8.36M	7.44M	7.91M	-226.00K	10.57M	N/A	N/A
Operating Income	16.01M	-35.68M	17.72M	21.24M	31.19M	25.50M	-16.59M	N/A	N/A
Other Expenses / Income	-137.12M	-228.22M	-10.10M	-5.32M	-21.50M	-2.09M	-23.29M	N/A	N/A
Before Tax Income	-121.11M	-263.90M	7.62M	15.91M	9.69M	6.11M	-31.97M	N/A	N/A
Income Tax Expenses	85.00K	-50.51M	-1.97M	1.19M	1.58M	1.66M	2.14M	N/A	N/A
Net Income	-156.23M	-213.39M	9.59M	16.41M	6.85M	-12.21M	-34.11M	N/A	N/A
Interest Expenses	40.68M	25.80M	1.11M	9.75M	21.58M	19.17M	14.23M	N/A	N/A
Basic Shares Outstanding	62.65M	61.39M	59.55M	56.83M	56.83M	55.63M	55.63M	54.23M	54.23M
Diluted Shares Outstanding	62.65M	61.39M	59.55M	56.83M	56.83M	55.63M	55.63M	54.23M	54.23M
EBITDA	73.38M	31.13M	52.60M	54.87M	62.16M	56.38M	15.34M	N/A	N/A
EBITDA Margin	14.32%	6.08%	12.21%	17.09%	18.27%	17.66%	6.05%	0.00%	0.00%
EBIT	-115.47M	-238.10M	8.73M	27.35M	30.01M	8.63M	-17.74M	N/A	N/A
EBIT Margin	-22.54%	-46.49%	2.03%	8.52%	8.82%	2.70%	-6.99%	0.00%	0.00%
Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2015-12-31	2014-12-31	2013-12-31